{"id":2764,"date":"2017-10-05T05:45:00","date_gmt":"2017-10-05T05:45:00","guid":{"rendered":"http:\/\/www.irlab.se\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/"},"modified":"2017-10-05T05:45:00","modified_gmt":"2017-10-05T05:45:00","slug":"irlab-erhaller-tillstand-fran-finska-lakemedelsverket","status":"publish","type":"post","link":"https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/","title":{"rendered":"IRLAB erh\u00e5ller tillst\u00e5nd fr\u00e5n finska l\u00e4kemedelsverket"},"content":{"rendered":"<p>&rdquo;Det &auml;r mycket tillfredst&auml;llande att &auml;nnu en l&auml;kemedelsmyndighet har granskat v&aring;r l&auml;kemedelskandidat IRL752, och givit sitt tillst&aring;nd till klinisk pr&ouml;vning. Att vi nu kan rekrytera patienter &auml;ven i Finland inneb&auml;r att studien f&ouml;rst&auml;rks med erfarna finska experter med l&aring;ng erfarenhet fr&aring;n behandling av Parkinsons sjukdom&rdquo;, s&auml;ger Joakim Tedroff, IRLAB:s medicinska chef, CMO.<\/p>\n<p>Fas II-studien, som &auml;r randomiserad, dubbelblind och placebokontrollerad, kommer att studera hur kognitiva och motoriska funktioner p&aring;verkas av behandling med IRL752 hos patienter med Parkinsons sjukdom och demens. Studiens prim&auml;ra syfte &auml;r att unders&ouml;ka s&auml;kerhet och tolererbarhet av IRL752.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>IRLAB Therapeutics AB har nu \u00e4ven erh\u00e5llit finska l\u00e4kemedelsverkets (FIMEA) och etiska kommitt\u00e9ns vid Universitetssjukhuset i Turkku tillst\u00e5nd att genomf\u00f6ra Fas II-studien med l\u00e4kemedelskandidaten IRL752 i Finland. Den 25 augusti 2017 meddelade IRLAB att bolaget f\u00e5tt tillst\u00e5nd fr\u00e5n svenska L\u00e4kemedelsverket att starta studien i Sverige.\u00a0<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[23],"tags":[],"class_list":["post-2764","post","type-post","status-publish","format-standard","hentry","category-pressmeddelande-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>IRLAB erh\u00e5ller tillst\u00e5nd fr\u00e5n finska l\u00e4kemedelsverket - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB erh\u00e5ller tillst\u00e5nd fr\u00e5n finska l\u00e4kemedelsverket - IRLAB\" \/>\n<meta property=\"og:description\" content=\"IRLAB Therapeutics AB har nu \u00e4ven erh\u00e5llit finska l\u00e4kemedelsverkets (FIMEA) och etiska kommitt\u00e9ns vid Universitetssjukhuset i Turkku tillst\u00e5nd att genomf\u00f6ra Fas II-studien med l\u00e4kemedelskandidaten IRL752 i Finland. Den 25 augusti 2017 meddelade IRLAB att bolaget f\u00e5tt tillst\u00e5nd fr\u00e5n svenska L\u00e4kemedelsverket att starta studien i Sverige.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta property=\"article:published_time\" content=\"2017-10-05T05:45:00+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"IRLAB erh\u00e5ller tillst\u00e5nd fr\u00e5n finska l\u00e4kemedelsverket\",\"datePublished\":\"2017-10-05T05:45:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/\"},\"wordCount\":141,\"commentCount\":0,\"articleSection\":[\"Pressmeddelande\"],\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/\",\"url\":\"https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/\",\"name\":\"IRLAB erh\u00e5ller tillst\u00e5nd fr\u00e5n finska l\u00e4kemedelsverket - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2017-10-05T05:45:00+00:00\",\"author\":{\"@id\":\"\"},\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IRLAB erh\u00e5ller tillst\u00e5nd fr\u00e5n finska l\u00e4kemedelsverket\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson&#039;s disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB erh\u00e5ller tillst\u00e5nd fr\u00e5n finska l\u00e4kemedelsverket - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB erh\u00e5ller tillst\u00e5nd fr\u00e5n finska l\u00e4kemedelsverket - IRLAB","og_description":"IRLAB Therapeutics AB har nu \u00e4ven erh\u00e5llit finska l\u00e4kemedelsverkets (FIMEA) och etiska kommitt\u00e9ns vid Universitetssjukhuset i Turkku tillst\u00e5nd att genomf\u00f6ra Fas II-studien med l\u00e4kemedelskandidaten IRL752 i Finland. Den 25 augusti 2017 meddelade IRLAB att bolaget f\u00e5tt tillst\u00e5nd fr\u00e5n svenska L\u00e4kemedelsverket att starta studien i Sverige.\u00a0","og_url":"https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/","og_site_name":"IRLAB","article_published_time":"2017-10-05T05:45:00+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/#article","isPartOf":{"@id":"https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/"},"author":{"name":"","@id":""},"headline":"IRLAB erh\u00e5ller tillst\u00e5nd fr\u00e5n finska l\u00e4kemedelsverket","datePublished":"2017-10-05T05:45:00+00:00","mainEntityOfPage":{"@id":"https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/"},"wordCount":141,"commentCount":0,"articleSection":["Pressmeddelande"],"inLanguage":"sv-SE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/","url":"https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/","name":"IRLAB erh\u00e5ller tillst\u00e5nd fr\u00e5n finska l\u00e4kemedelsverket - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2017-10-05T05:45:00+00:00","author":{"@id":""},"breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/irlab-erhaller-tillstand-fran-finska-lakemedelsverket\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"IRLAB erh\u00e5ller tillst\u00e5nd fr\u00e5n finska l\u00e4kemedelsverket"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson&#039;s disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts\/2764","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/comments?post=2764"}],"version-history":[{"count":0,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts\/2764\/revisions"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=2764"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/categories?post=2764"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/tags?post=2764"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}